These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2702798

  • 1. The pharmacokinetics of the enantiomers of atenolol.
    Boyd RA, Chin SK, Don-Pedro O, Williams RL, Giacomini KM.
    Clin Pharmacol Ther; 1989 Apr; 45(4):403-10. PubMed ID: 2702798
    [Abstract] [Full Text] [Related]

  • 2. Stereoselective renal clearance of pindolol in humans.
    Hsyu PH, Giacomini KM.
    J Clin Invest; 1985 Nov; 76(5):1720-6. PubMed ID: 4056049
    [Abstract] [Full Text] [Related]

  • 3. Effects of orange juice on the pharmacokinetics of atenolol.
    Lilja JJ, Raaska K, Neuvonen PJ.
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men.
    Wang XM, Yu XY, Lin SG.
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):367-70. PubMed ID: 10452127
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of atenolol enantiomers in humans and rats.
    Mehvar R, Gross ME, Kreamer RN.
    J Pharm Sci; 1990 Oct; 79(10):881-5. PubMed ID: 2280355
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J, Pozet N, McAinsh J, Legheand J, Zech P.
    Eur J Clin Pharmacol; 1977 Nov 14; 12(3):175-80. PubMed ID: 590303
    [Abstract] [Full Text] [Related]

  • 7. Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure.
    Belpaire FM, Rosseel MT, Vermeulen AM, De Smet F, Bogaert MG.
    Mech Ageing Dev; 1993 Feb 14; 67(1-2):201-10. PubMed ID: 8469031
    [Abstract] [Full Text] [Related]

  • 8. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ, Juntti-Patinen L, Neuvonen PJ.
    Basic Clin Pharmacol Toxicol; 2006 Jun 14; 98(6):555-8. PubMed ID: 16700816
    [Abstract] [Full Text] [Related]

  • 9. Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome.
    Phelps SJ, Alpert BS, Ward JL, Pieper JA, Lima JJ.
    J Clin Pharmacol; 1995 Mar 14; 35(3):268-74. PubMed ID: 7608315
    [Abstract] [Full Text] [Related]

  • 10. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
    Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S.
    Chirality; 1994 Mar 14; 6(3):169-74. PubMed ID: 8024947
    [Abstract] [Full Text] [Related]

  • 11. Liquid chromatographic analysis of atenolol enantiomers in human plasma and urine.
    Mehvar R.
    J Pharm Sci; 1989 Dec 14; 78(12):1035-9. PubMed ID: 2575664
    [Abstract] [Full Text] [Related]

  • 12. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
    Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W.
    Chirality; 1993 Dec 14; 5(1):15-9. PubMed ID: 8383518
    [Abstract] [Full Text] [Related]

  • 13. Determination of biological equivalence of two atenolol preparations.
    Wolf-Coporda A, Plavsić F, Vrhovac B.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct 14; 25(10):567-71. PubMed ID: 3323073
    [Abstract] [Full Text] [Related]

  • 14. Direct enantiospecific HPLC bioanalysis of (R,S)-atenolol on a chiral stationary phase.
    Kofahl B, Henke D, Mutschler E.
    Chirality; 1993 Oct 14; 5(6):479-82. PubMed ID: 8398605
    [Abstract] [Full Text] [Related]

  • 15. Kinetics and absolute bioavailability of atenolol.
    Mason WD, Winer N, Kochak G, Cohen I, Bell R.
    Clin Pharmacol Ther; 1979 Apr 14; 25(4):408-15. PubMed ID: 428185
    [Abstract] [Full Text] [Related]

  • 16. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML, Pierossi MA, Moraes LA, Ribeiro W, Abbib Júnior E, Mendes GB, Poli A, De Nucci G, Muscará MN.
    Int J Clin Pharmacol Ther; 1997 Aug 14; 35(8):324-8. PubMed ID: 9266287
    [Abstract] [Full Text] [Related]

  • 17. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
    Egginger G, Lindner W, Kahr S, Stoschitzky K.
    Chirality; 1993 Aug 14; 5(7):505-12. PubMed ID: 8240927
    [Abstract] [Full Text] [Related]

  • 18. Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
    Enquist M, Hermansson J.
    Chirality; 1989 Aug 14; 1(3):209-15. PubMed ID: 2642050
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of atenolol in clinically normal cats.
    Quiñones M, Dyer DC, Ware WA, Mehvar R.
    Am J Vet Res; 1996 Jul 14; 57(7):1050-3. PubMed ID: 8807020
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC, Carruthers SG, Johnston GD, Kelly JG, McAinsh J, McDevitt DG, Shanks RG.
    Clin Pharmacol Ther; 1976 Nov 14; 20(5):524-34. PubMed ID: 10125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.